IMI/REL (MK-7655A) vs. PIP/TAZ in Treatment of Subjects with HABP/VABP

Update Il y a 4 ans
Reference: EUCTR2015-000246-34

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the incidence rate of all-cause mortality through Day 28 post-randomization associated with treatment with IMI/REL compared to treatment with PIP/TAZ in subjects diagnosed with HABP/VABP in the modified intention-to-treat (MITT) population.


Inclusion criteria

  • Treatment for hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP)